Merck (MRK) Gross Profit (2009 - 2026)

Merck has disclosed Gross Profit across 18 years of filings, most recently posting $12.1 billion for Q1 2026.

• In Q1 2026, Gross Profit changed 0.16% year-over-year to $12.1 billion; the TTM figure through Mar 2026 stood at $48.6 billion (changed 0.49% YoY), while the FY2025 annual figure was $48.6 billion, down 0.71% from the prior year.
• Gross Profit climbed to $12.1 billion in Q1 2026, from $10.8 billion in the prior quarter.
• Over the last five years, Gross Profit for MRK reached as high as $13.4 billion in Q3 2025 and fell as low as $9.9 billion in Q4 2022.
• The 5-year median for Gross Profit is $11.7 billion (2023), against an average of $11.5 billion.
• Annual changes were most pronounced in 2022 — Gross Profit soared 41.64% — and 2025, when it retreated 8.03%.
• A 5-year view of Gross Profit shows it stood at $9.9 billion in 2022, then advanced by 7.73% to $10.7 billion in 2023, then gained by 10.06% to $11.8 billion in 2024, then dropped by 8.03% to $10.8 billion in 2025, then climbed by 11.45% to $12.1 billion in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $12.1 billion, $10.8 billion, and $13.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.